Document And Entity Information
Document And Entity Information - USD ($) | 12 Months Ended | ||
Nov. 30, 2020 | May 20, 2021 | May 31, 2020 | |
Document Information Line Items | |||
Entity Registrant Name | Sipup Corp | ||
Document Type | 10-K | ||
Current Fiscal Year End Date | --11-30 | ||
Entity Common Stock, Shares Outstanding | 24,044,000 | ||
Entity Public Float | $ 457,500 | ||
Amendment Flag | false | ||
Entity Central Index Key | 0001563227 | ||
Entity Current Reporting Status | No | ||
Entity Voluntary Filers | No | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Well-known Seasoned Issuer | No | ||
Document Period End Date | Nov. 30, 2020 | ||
Document Fiscal Year Focus | 2020 | ||
Document Fiscal Period Focus | FY | ||
Entity Small Business | true | ||
Entity Emerging Growth Company | false | ||
Entity Shell Company | true | ||
Entity File Number | 333-185408 | ||
Entity Incorporation, State or Country Code | NV | ||
Entity Interactive Data Current | No |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) | Nov. 30, 2020 | Nov. 30, 2019 |
Current assets: | ||
Prepaid expenses (Note 4) | $ 7,200 | $ 93,600 |
Total assets | 7,200 | 93,600 |
LIABILITIES AND STOCKHOLDERS’ DEFICIENCY | ||
Accounts payable and accrued expenses | 88,200 | 113,352 |
Loan from stockholder (Note 3) | 172,882 | 161,515 |
Total liabilities | 261,082 | 274,867 |
Stockholders’ deficiency: | ||
Common stock, $0.001 par value; 75,000,000 shares authorized; 24,044,000 shares issued and outstanding on November 30, 2020 November 30, 2019 respectively | 24,044 | 24,044 |
Additional paid-in capital | 64,631 | 64,631 |
Shareholder debt due to issuance of shares | (55,647) | (55,647) |
Accumulated deficit | (286,910) | (214,295) |
Total stockholders’ deficiency | (253,882) | (181,267) |
Total liabilities and stockholders’ deficiency | $ 7,200 | $ 93,600 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parentheticals) - $ / shares | Nov. 30, 2020 | Nov. 30, 2019 |
Statement of Financial Position [Abstract] | ||
Common stock, par value (in Dollars per share) | $ 0.001 | $ 0.001 |
Common stock, shares authorized | 75,000,000 | 75,000,000 |
Common stock, shares issued | 24,044,000 | 24,044,000 |
Common stock, shares outstanding | 24,044,000 | 24,044,000 |
Consolidated Statements of Oper
Consolidated Statements of Operations - USD ($) | 12 Months Ended | |
Nov. 30, 2020 | Nov. 30, 2019 | |
Income Statement [Abstract] | ||
Revenues: | ||
Operating expenses: | ||
General and administrative expenses | 61,248 | 48,800 |
Total operating expenses | 61,248 | 48,800 |
Interest on shareholder loan | 11,367 | 6,090 |
Net loss | $ (72,615) | $ (54,890) |
Net loss per share-basic and diluted attributable to common stockholders (in Dollars per share) | $ 0 | $ 0 |
Basic and diluted weighted average number of shares outstanding (in Shares) | 24,044,000 | 23,523,397 |
Statements of Stockholders_ Def
Statements of Stockholders’ Deficiency Equity - USD ($) | Common Stock | Additional Paid-in Capital | Accumulated Deficit | Shareholder debt due to issuance of shares | Total |
Beginning Balance at Nov. 30, 2018 | $ 18,000 | $ (159,405) | $ (141,405) | ||
Beginning Balance (in Shares) at Nov. 30, 2018 | 18,000,000 | ||||
Effect of Reverse Capitalization | $ 6,044 | 64,631 | 70,675 | ||
Effect of Reverse Capitalization (in Shares) | 6,044,000 | ||||
Shareholder debt due to issuance of shares | (55,647) | (55,647) | |||
Loss for the period | (54,890) | (54,890) | |||
Ending Balance at Nov. 30, 2019 | $ 24,044 | 64,631 | (214,295) | (55,647) | (181,267) |
Ending Balance (in Shares) at Nov. 30, 2019 | 24,044,000 | ||||
Loss for the period | (72,615) | (2,615) | |||
Ending Balance at Nov. 30, 2020 | $ 24,044 | $ 64,631 | $ (286,910) | $ (55,647) | $ (253,882) |
Ending Balance (in Shares) at Nov. 30, 2020 | 24,044,000 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) | 12 Months Ended | |
Nov. 30, 2020 | Nov. 30, 2019 | |
Statement of Cash Flows [Abstract] | ||
Net loss | $ (72,615) | $ (54,890) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Interest on shareholder’s loan | 11,367 | 6,090 |
Stock based compensation | 86,400 | 43,200 |
Changes in operating assets and liabilities: | ||
(Decrease) Increase in accounts payable and accrued expenses | (25,152) | 5,600 |
Net cash used in operating activities | ||
Increase in cash and cash equivalents | ||
Cash and cash equivalents at beginning of period | ||
Cash and cash equivalents at end of period |
Nature of Business and Basis of
Nature of Business and Basis of Presentation | 12 Months Ended |
Nov. 30, 2020 | |
Accounting Policies [Abstract] | |
NATURE OF BUSINESS AND BASIS OF PRESENTATION | NOTE 1 – NATURE OF BUSINESS AND BASIS OF PRESENTATION Sipup Corporation (the “Company”) is a Nevada Corporation incorporated on October 31, 2012. For additional information see subsequent events Merger Transaction On June 2, 2019, the Company completed the acquisition of Enlightened Capital Ltd., an Israeli company with offices at Bnei-Brak, Israel (“Enlightened”) whereby Enlightened became a direct and wholly owned subsidiary of the Company. As consideration, the Company issued to Enlightened’s shareholders 18,000,000 common Stock, par value $0.001 per share. Enlightened is engaged, in the field of green energy and is licensed to internationally trade in Certified Emission Reductions, also known as carbon credits (“CERs”), as issued by the UN until 2040. The transaction was accounted for as a reverse asset acquisition in accordance with generally accepted accounting principles in the United States of America (“GAAP”). Under this method of accounting, Enlightened was deemed to be the accounting acquirer for financial reporting purposes. This determination was primarily based on the facts that, immediately following the Merger: (i) Enlightened’s stockholders owned a substantial majority of the voting rights in the combined company. As a result of the Recapitalization Transaction, the shareholders of Enlightened received the largest ownership interest in the Company, and Enlightened was determined to be the “accounting acquirer” in the Recapitalization Transaction. As a result, the historical financial statements of the Company were replaced with the historical financial statements of Enlightened. The number of shares prior to the reverse capitalization have been retroactively adjusted based on the equivalent number of shares received by the accounting acquirer in the Recapitalization Transaction. Going concern The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. As of November 30, 2020, the Company has an accumulated deficit of $286,910 from operations and has earned no revenues to cover its operating costs. The Company intends to fund future operations through equity financing arrangements, which may be insufficient to fund its capital expenditures, working capital and other cash requirements for the year ending November 30, 2020. The ability of the Company to emerge from the development stage is dependent upon, among other things, obtaining additional financing to continue operations, and development of its business plan. In response to these problems, management intends to raise additional funds through public or private placement offerings. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 12 Months Ended |
Nov. 30, 2020 | |
Accounting Policies [Abstract] | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES The financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (US GAAP). Basis of Presentation The Company maintains its accounting records on an accrual basis in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”). These financial statements are presented in US dollars. Use of estimates in the preparation of consolidated financial statements The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates. As applicable to these financial statements, the most significant estimates and assumptions relate to the going concern assumptions. Cash and cash equivalents, and Restricted cash Cash equivalents are short-term highly liquid investments which include short term bank deposits (up to three months from date of deposit), that are not restricted as to withdrawals or use that are readily convertible to cash with maturities of three months or less as of the date acquired. The Company maintains its cash balances at credit-worthy financial institutions that are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. Earnings per Share The Company computes net loss per share in accordance with ASC 260, “Earnings Per Share” ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is calculated by dividing the profit or loss attributable to common shareholders of the Company by the weighted average number of common shares outstanding during the period. Diluted EPS is determined by adjusting the profit or loss attributable to common shareholders and the weighted average number of common shares outstanding for the effects of all potential dilutive common shares, which comprise options granted to employees. As November 30, 2020, the Company had no potentially dilutive shares. Income Taxes Income taxes are accounted for in accordance with ASC Topic 740, “Income Taxes.” Under the asset and liability method, deferred tax assets and liabilities are recognized for the future consequences of differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases (temporary differences). Deferred tax assets and liabilities are measured using tax rates expected to apply to taxable income in the years in which those temporary differences are recovered or settled. Valuation allowances for deferred tax assets are established when it is more likely than not that some portion or all of the deferred tax assets will not be realized. Stock based compensation The Company accounts for equity instruments issued to employees in accordance with ASC 718, Compensation - Stock Compensation. ASC 718 requires all share-based compensation payments to be recognized in the financial statements based on the fair value using an option pricing model. ASC 718 requires forfeitures to be estimated at the time of grant and revised in subsequent periods if actual forfeitures differ from initial estimates. Equity instruments granted to non-employees are accounted for in accordance with ASC 505, Equity. The final measurement date for the fair value of equity instruments with performance criteria is the date that each performance commitment for such equity instrument is satisfied or there is a significant disincentive for non-performance. Fair Value of Financial Instruments The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level. The following are the hierarchical levels of inputs to measure fair value: - Level 1: Quoted prices in active markets for identical instruments. - Level 2: Other significant observable inputs (including quoted prices in active markets for similar instruments); - Level 3: Significant unobservable inputs (including assumptions in determining the fair value of certain investments). |
Loan from Stockholder
Loan from Stockholder | 12 Months Ended |
Nov. 30, 2020 | |
Loan From Stockholder [Abstract] | |
LOAN FROM STOCKHOLDER | NOTE 3 – LOAN FROM STOCKHOLDER As of year ended, November 30, November 30, Loan from shareholder (*) $ 158,862 $ 147,495 Loan from related party (**) 14,020 14,020 $ 172,882 $ 161,515 (*) The loan is unsecured, bears annual 2.56% interest and has no repayment term. This loan is repayable on demand (**) The loan is unsecured, bears no interest and has no repayment term. This loan is repayable on demand |
Stockholders' Deficit
Stockholders' Deficit | 12 Months Ended |
Nov. 30, 2020 | |
Stockholders' Equity Note [Abstract] | |
STOCKHOLDERS' DEFICIT | NOTE 4 – STOCKHOLDERS’ DEFICIT Common stock During March 2019, the Company issued Adi Zim Holdings Ltd. (“Adi”) 644,000 restricted shares of the Company’s common stock in consideration for remittance of $100,000 for purposes of paying outstanding Company obligation to third parties. During April 2019, the Company and Rosario Capital Ltd. (“Rosario”) have entered into additional service agreement, pursuant to which Rosario is providing to the Company certain financial advisory and other services. In consideration of any and all Rosario's Services, the Company has issued to Rosario 900,000 restricted shares of common stock. The service agreement will be terminated on December 31, 2020. The fair value of the restricted shares as of the date of issuance was $144,000 using the share price on the day of issuance. During the year ended November 30, 2020 the Company recorded $86,400 as professional fees. |
Income Taxes
Income Taxes | 12 Months Ended |
Nov. 30, 2020 | |
Income Tax Disclosure [Abstract] | |
INCOME TAXES | NOTE 5 – INCOME TAXES a. Provision for income taxes No provision for income taxes was required for the year ended November 3 , 2020 and 2019 due to net losses in these periods. b. In accordance with ASC 740-10, the components of deferred income taxes are as follows: As of November 30, 2020 2019 Net operating losses carryforwards $ 60,251 $ 45,002 Less valuation allowance (60,251 ) (45,002 ) Net deferred tax assets $ - $ - The Company provided a valuation allowance equal to the deferred income tax assets for period ended November 3 . As of November 3 The Company did not identify any material uncertain tax positions. The Company did not recognize any interest or penalties for unrecognized tax benefits. The federal income tax returns of the Company are subject to examination by the IRS, generally for three years after they are filed . |
Related Party Transaction
Related Party Transaction | 12 Months Ended |
Nov. 30, 2020 | |
Related Party Transactions [Abstract] | |
RELATED PARTY TRANSACTION | NOTE 6 – RELATED PARTY TRANSACTION The following transactions were carried out with related parties: As of November 30, 2020 2019 General and administrative expenses $ 86,400 $ 43,200 Interest on shareholder’s loan 11,367 6,090 For additional information please refer to Note 3. |
Subsequent Events
Subsequent Events | 12 Months Ended |
Nov. 30, 2020 | |
Subsequent Events [Abstract] | |
SUBSEQUENT EVENTS | NOTE 7 – SUBSEQUENT EVENTS (i) During December 2020 the company, in consideration of the advance of $50,000 for purposes of paying outstanding Company obligation to third parties, the Company issued to Adi Zim and Rosario Capital Ltd. its unsecured convertible promissory note in the principal amount of $50,000 (the “Note”). The Note is repaybale upon the earlier of December 15, 2021 and the closing of the Stock Exchange Agreement with VeganNation.The Note is convertible into shares of the Company’s common stock at a rate equal to $0.10 per share, and upon (and subject to) the conversion of the Note. During the three months ended February 28, 2021 the Company received $45,000 out of $50,000. (ii) On April 25, 2021, the Company entered into a Stock Exchange Agreement with VeganNation Services Ltd., a company formed under the laws of the State of Israel (“VeganNation”) and the shareholders of VeganNation pursuant to which VeganNation would become a wholly owned subsidiary of the Company, and the shareholders of VeganNation would receive an aggregate of 23,562,240 shares of common stock of the Company. The transaction is subject to customary closing conditions. VeganNation is, a leading global plant-based company building an all-encompassing conscious consumer ecosystem, connecting and empowering plant-based and sustainable businesses and individuals. Management of the Company believes that the growth of sustainable and plant-based consumer goods presents a unique opportunity to participate in the fastest growing lifestyle globally. In connection with the proposed transaction, the VeganNation stockholders are expected to receive comon stock of Sipup that will be equal to approximately 50% of the issued and outstanding common stock of the Company at the closing of the proposed merger, on a fully diluted basis. Following the closing of the proposed merger, VeganNation will effect a change in the Company’s Board of Directors and management |
Accounting Policies, by Policy
Accounting Policies, by Policy (Policies) | 12 Months Ended |
Nov. 30, 2020 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The Company maintains its accounting records on an accrual basis in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”). These financial statements are presented in US dollars. |
Use of estimates in the preparation of consolidated financial statements | Use of estimates in the preparation of consolidated financial statements The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates. As applicable to these financial statements, the most significant estimates and assumptions relate to the going concern assumptions. |
Cash and cash equivalents, and Restricted cash | Cash and cash equivalents, and Restricted cash Cash equivalents are short-term highly liquid investments which include short term bank deposits (up to three months from date of deposit), that are not restricted as to withdrawals or use that are readily convertible to cash with maturities of three months or less as of the date acquired. The Company maintains its cash balances at credit-worthy financial institutions that are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. |
Earnings per Share | Earnings per Share The Company computes net loss per share in accordance with ASC 260, “Earnings Per Share” ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is calculated by dividing the profit or loss attributable to common shareholders of the Company by the weighted average number of common shares outstanding during the period. Diluted EPS is determined by adjusting the profit or loss attributable to common shareholders and the weighted average number of common shares outstanding for the effects of all potential dilutive common shares, which comprise options granted to employees. As November 30, 2020, the Company had no potentially dilutive shares. |
Income Taxes | Income Taxes Income taxes are accounted for in accordance with ASC Topic 740, “Income Taxes.” Under the asset and liability method, deferred tax assets and liabilities are recognized for the future consequences of differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases (temporary differences). Deferred tax assets and liabilities are measured using tax rates expected to apply to taxable income in the years in which those temporary differences are recovered or settled. Valuation allowances for deferred tax assets are established when it is more likely than not that some portion or all of the deferred tax assets will not be realized. |
Stock based compensation | Stock based compensation The Company accounts for equity instruments issued to employees in accordance with ASC 718, Compensation - Stock Compensation. ASC 718 requires all share-based compensation payments to be recognized in the financial statements based on the fair value using an option pricing model. ASC 718 requires forfeitures to be estimated at the time of grant and revised in subsequent periods if actual forfeitures differ from initial estimates. Equity instruments granted to non-employees are accounted for in accordance with ASC 505, Equity. The final measurement date for the fair value of equity instruments with performance criteria is the date that each performance commitment for such equity instrument is satisfied or there is a significant disincentive for non-performance. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level. The following are the hierarchical levels of inputs to measure fair value: - Level 1: Quoted prices in active markets for identical instruments. - Level 2: Other significant observable inputs (including quoted prices in active markets for similar instruments); - Level 3: Significant unobservable inputs (including assumptions in determining the fair value of certain investments). |
Loan from Stockholder (Tables)
Loan from Stockholder (Tables) | 12 Months Ended |
Nov. 30, 2020 | |
Loan From Stockholder [Abstract] | |
Schedule of loan from stockholder | As of year ended, November 30, November 30, Loan from shareholder (*) $ 158,862 $ 147,495 Loan from related party (**) 14,020 14,020 $ 172,882 $ 161,515 (*) The loan is unsecured, bears annual 2.56% interest and has no repayment term. This loan is repayable on demand (**) The loan is unsecured, bears no interest and has no repayment term. This loan is repayable on demand |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Nov. 30, 2020 | |
Income Tax Disclosure [Abstract] | |
Schedule of deferred income taxes | As of November 30, 2020 2019 Net operating losses carryforwards $ 60,251 $ 45,002 Less valuation allowance (60,251 ) (45,002 ) Net deferred tax assets $ - $ - |
Related Party Transaction (Tabl
Related Party Transaction (Tables) | 12 Months Ended |
Nov. 30, 2020 | |
Related Party Transactions [Abstract] | |
Schedule of related party transactions | As of November 30, 2020 2019 General and administrative expenses $ 86,400 $ 43,200 Interest on shareholder’s loan 11,367 6,090 |
Nature of Business and Basis _2
Nature of Business and Basis of Presentation (Details) - USD ($) | Nov. 30, 2020 | Nov. 30, 2019 |
Accounting Policies [Abstract] | ||
Share of common stock | 18,000,000 | |
Common stock, par value | $ 0.001 | $ 0.001 |
Accumulated deficit | $ (286,910) | $ (214,295) |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Details) | 12 Months Ended |
Nov. 30, 2020USD ($) | |
Accounting Policies [Abstract] | |
Maturity term | 3 months |
Federal deposit insurance corporation, amount | $ 250,000 |
Loan from Stockholder (Details)
Loan from Stockholder (Details) | Nov. 30, 2020 |
Loan From Stockholder [Abstract] | |
Bears annual interest | 2.56% |
Loan from Stockholder (Detail_2
Loan from Stockholder (Details) - Schedule of loan from stockholder - USD ($) | Nov. 30, 2020 | Nov. 30, 2019 | |
Schedule of loan from stockholder [Abstract] | |||
Loan from shareholder | [1] | $ 158,862 | $ 147,495 |
Loan from related party | [2] | 14,020 | 14,020 |
Total Loan from stockholder | $ 172,882 | $ 161,515 | |
[1] | The loan is unsecured, bears annual 2.56% interest and has no repayment term. This loan is repayable on demand | ||
[2] | The loan is unsecured, bears no interest and has no repayment term. This loan is repayable on demand |
Stockholders' Deficit (Details)
Stockholders' Deficit (Details) - USD ($) | 1 Months Ended | |
Mar. 31, 2020 | Apr. 30, 2019 | |
Stockholders' Equity Note [Abstract] | ||
Restricted shares | 644,000 | 900,000 |
Remittance of paying outstanding (in Dollars) | $ 100,000 | |
Fair value of restricted shares | 144,000 | |
Professional fees (in Dollars) | $ 86,400 |
Income Taxes (Details)
Income Taxes (Details) | 12 Months Ended |
Nov. 30, 2020USD ($) | |
Income Tax Disclosure [Abstract] | |
Operating loss carryforwards | $ 286,910 |
Operating loss carryforwards expiration, description | expire by the year 2038 |
Income Taxes (Details) - Schedu
Income Taxes (Details) - Schedule of deferred income taxes - USD ($) | Nov. 30, 2020 | Nov. 30, 2019 |
Schedule of deferred income taxes [Abstract] | ||
Net operating losses carryforwards | $ 60,251 | $ 45,002 |
Less valuation allowance | (60,251) | (45,002) |
Net deferred tax assets |
Related Party Transaction (Deta
Related Party Transaction (Details) - Schedule of related party transactions - USD ($) | 12 Months Ended | |
Nov. 30, 2020 | Nov. 30, 2019 | |
Schedule of related party transactions [Abstract] | ||
General and administrative expenses | $ 86,400 | $ 43,200 |
Interest on shareholder’s loan | $ 11,367 | $ 6,090 |
Subsequent Events (Details)
Subsequent Events (Details) - USD ($) | 1 Months Ended | ||
Apr. 25, 2021 | Feb. 28, 2021 | Dec. 31, 2020 | |
Subsequent Event [Member] | |||
Subsequent Events (Details) [Line Items] | |||
Consideration advances | $ 50,000 | ||
Principal amount | $ 50,000 | ||
Common stock rate equal to per share (in Dollars per share) | $ 0.10 | ||
Payment received amount | $ 45,000 | ||
Total amount | $ 50,000 | ||
Forecast [Member] | |||
Subsequent Events (Details) [Line Items] | |||
Aggregate of shares of common stock (in Shares) | 23,562,240 | ||
Percentage of issued and outstanding common stock | 50.00% |